These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2567936)

  • 1. Ceftriaxone-associated biliary pseudolithiasis in adults.
    Pigrau C; Pahissa A; Gropper S; Sureda D; Martinez Vazquez JM
    Lancet; 1989 Jul; 2(8655):165. PubMed ID: 2567936
    [No Abstract]   [Full Text] [Related]  

  • 2. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
    Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
    Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transitory biliary pseudolithiasis appearing quickly after ceftriaxone treatment].
    Chevrel J; Barbier R; Mondeteguy J
    Arch Pediatr; 1999 Mar; 6(3):336. PubMed ID: 10191906
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biliary pseudolithiasis due to ceftriaxone].
    García Alonso JA; Montejo Baranda M; de la Prieta López R; Aguirre Errasti C
    Med Clin (Barc); 1993 May; 100(17):677-8. PubMed ID: 8497180
    [No Abstract]   [Full Text] [Related]  

  • 8. Ceftriaxone and biliary pseudolithiasis.
    Billstein SA; Sudol TE
    Pediatr Infect Dis J; 1988 Nov; 7(11):818-20. PubMed ID: 3231507
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
    Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
    Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ceftriaxone-associated biliary pseudolithiasis in a child].
    Wang YQ
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):251. PubMed ID: 15924712
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.
    Kirejczyk WM; Crowe HM; Mackay IM; Quintiliani R; Cronin EB
    AJR Am J Roentgenol; 1992 Aug; 159(2):329-30. PubMed ID: 1632349
    [No Abstract]   [Full Text] [Related]  

  • 13. Ceftriaxone-associated biliary pseudolithiasis in children.
    Herek O; Pakdemirli E; Koçer N
    Eur Radiol; 2001; 11(5):902. PubMed ID: 11372630
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case report; a case of biliary pseudolithiasis associated with ceftriaxone].
    Hanata N; Imamura T; Koyama R; Koizumi Y; Tamura T; Ito J; Takeuch K
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2955-7. PubMed ID: 23214106
    [No Abstract]   [Full Text] [Related]  

  • 15. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.
    Yoshida R; Yoshizako T; Katsube T; Kitagaki H
    Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of ceftriaxone-associated gallbladder pseudolithiasis.
    Papadopoulou F; Efremidis S; Karyda S; Badouraki M; Karatza E; Panteliadis C; Malaka K
    Acta Paediatr; 1999 Dec; 88(12):1352-5. PubMed ID: 10626521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudolithiasis caused by ceftriaxone in children: a case report].
    Benedetti M; Zanchetta S; Bagnani A; Praderio R; Perbellini S; Melo C
    Pediatr Med Chir; 1995; 17(4):369-71. PubMed ID: 7491336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children.
    Palanduz A; Yalçin I; Tonguç E; Güler N; Oneş U; Salman N; Somer A
    J Clin Ultrasound; 2000 May; 28(4):166-8. PubMed ID: 10751736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.